High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients
- 23 March 2012
- journal article
- research article
- Published by Elsevier in Pharmacological Research
- Vol. 65 (6), 615-620
- https://doi.org/10.1016/j.phrs.2012.03.009
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- A Short Screener Is Valid for Assessing Mediterranean Diet Adherence among Older Spanish Men and WomenJournal of Nutrition, 2011
- Cohort Profile: Design and methods of the PREDIMED studyInternational Journal of Epidemiology, 2010
- Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of SpainBritish Journal of Nutrition, 2010
- Protein deacetylation by SIRT1: An emerging key post-translational modification in metabolic regulationPharmacological Research, 2009
- The insulin-suppressive effect of resveratrol — An in vitro and in vivo phenomenonLife Sciences, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Resveratrol inhibits insulin responses in a SirT1-independent pathwayBiochemical Journal, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Antidiabetic Activity of Red Wine Polyphenolic Extract, Ethanol, or Both in Streptozotocin-Treated RatsJournal of Agricultural and Food Chemistry, 2004